Breast Cancer Research and Treatment

, Volume 120, Issue 3, pp 777–782

Mismatch repair defective breast cancer in the hereditary nonpolyposis colorectal cancer syndrome

  • Uffe Birk Jensen
  • Lone Sunde
  • Susanne Timshel
  • Britta Halvarsson
  • Anja Nissen
  • Inge Bernstein
  • Mef Nilbert
Brief Report

DOI: 10.1007/s10549-009-0449-3

Cite this article as:
Jensen, U.B., Sunde, L., Timshel, S. et al. Breast Cancer Res Treat (2010) 120: 777. doi:10.1007/s10549-009-0449-3

Abstract

Whether or not breast cancer can be a feature of the hereditary nonpolyposis colorectal cancer (HNPCC) syndrome has been debated. In order to clarify if defective mismatch repair (MMR) may indeed play a role in breast cancer, we used the Danish HNPCC register to identify all breast cancers that occurred in MMR gene mutation carriers. In total, 20 female mutation carriers were diagnosed with breast cancer at mean 50 years of age. These tumors were predominantly ductal carcinomas with extensive lymphocytic reactions in 8/14 evaluated tumors. MMR protein immunostaining showed loss of expression of MLH1, MSH2 or MSH6 corresponding to the mutations identified in 7 of the 16 cases investigated, and these tumors were diagnosed at mean 50 (33–66) years of age. The demonstration of defective MMR in a substantial proportion of the breast cancers studied links yet another tumor type to HNPCC. Though the low number do not motivate surveillance, our observation supports a role for defective MMR in breast cancer progression in HNPCC, presumably through accelerated accumulation of mutations in breast cancer-associated genes.

Keywords

HNPCC MMR MLH1 MSH2 MSH6 Hereditary cancer 

Copyright information

© Springer Science+Business Media, LLC. 2009

Authors and Affiliations

  • Uffe Birk Jensen
    • 1
  • Lone Sunde
    • 1
  • Susanne Timshel
    • 4
  • Britta Halvarsson
    • 2
  • Anja Nissen
    • 3
  • Inge Bernstein
    • 4
  • Mef Nilbert
    • 3
  1. 1.Department of Clinical GeneticsÅrhus University HospitalÅrhusDenmark
  2. 2.Department of PathologyHelsingborg HospitalHelsingborgSweden
  3. 3.Clinical Research Centre, Hvidovre HospitalCopenhagen UniversityHvidovreDenmark
  4. 4.HNPCC-register, Hvidovre HospitalCopenhagen UniversityHvidovreDenmark